SISCAPA | GenomeWeb


The company plans to offer the immuno-MRM assays as kits covering sample prep and protein digestion as well as immuno-enrichment of specific peptides.

The project aims to develop multiple-reaction monitoring mass spec and immuno-MRM mass spec assays for roughly 100 proteins involved in RAS signaling.

NEW YORK (GenomeWeb) – New England Peptide and SISCAPA Assay Technologies are collaborating to manufacture and sell stable isotope standard peptides for use in SISCAPA's protein quantification assays.

NEW YORK (GenomeWeb News) – OriGene Technologies announced that it has received a contract from the National Cancer Institute to develop high affinity anti-peptide antibodies for SISCAPA assays.

NEW YORK (GenomeWeb News) – Bruker said today at the 12th annual meeting of the Human Proteome Organization in Yokohama, Japan, that it has launched a second-phase collaboration agreement with SISCAPA Assays Technologies to apply the SISCAPA immunoenrichment mass spec method to its MALDI-TOF inst

Researchers from Agilent and SISCAPA Assay Technologies have developed a targeted mass spec workflow that allows for multiple-reaction monitoring-based quantitation of proteins with sample cycle times as short as seven seconds.

Thermo Fisher Scientific last week announced a collaboration with German diagnostics firm Immundiagnostik for development of mass spec-based assays for protein and peptide quantitation.

While targeted mass spec techniques like multiple-reaction monitoring continue to wrestle with issues of sample preparation, throughput, and sensitivity, recent publications and presentations suggest that the technology has gained a foothold in both industry and academia as a res

The National Cancer Institute's Small Business Innovation Research Development Center this week announced $10 million in new contract funding opportunities, including several for proteomics research reagents.

Researchers at Pacific Northwest National Laboratory and the National Cancer Institute have developed a new selected-reaction monitoring mass spectrometry-based technique capable of quantifying proteins at low picogram-per-mL levels without the use of immunoenrichment.


In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.